CNS Pharmaceuticals, Inc.
CNSP
$4.59
-$0.30-6.14%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -16.49M | -15.85M | -13.07M | -15.46M | -15.61M |
| Total Depreciation and Amortization | 4.70K | 3.90K | 3.90K | 4.00K | 3.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 130.50K | 190.30K | 232.60K | 1.08M | 1.29M |
| Change in Net Operating Assets | 1.13M | 1.85M | -3.40M | -6.48M | -2.85M |
| Cash from Operations | -15.22M | -13.81M | -16.23M | -20.86M | -17.16M |
| Capital Expenditure | -24.40K | -18.20K | -4.20K | -4.20K | -4.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -24.40K | -18.20K | -4.20K | -4.20K | -4.20K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -306.90K | -297.60K | -298.00K | -299.10K | -300.10K |
| Issuance of Common Stock | 5.52M | 14.05M | 18.55M | 30.97M | 28.88M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -65.60K | 816.40K | 870.50K | 832.00K | 815.20K |
| Cash from Financing | 5.15M | 14.57M | 19.13M | 31.50M | 29.40M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -10.10M | 739.60K | 2.89M | 10.64M | 12.23M |